MDxHealth SA Ordinary Shares (MDXH) Stock: Buy, Sell, or Hold?
MDXH - MDxHealth SA Ordinary Shares
$0.55
-0.02 (-3.04%)
▼
5d:
-8.67%
30d:
-24.05%
90d:
+37.0%
WAIT
LOW Confidence
Analysis Updated: Sep 28, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When MDXH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MDXH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MDXH shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDXH is currently trading at $0.55, which is considered oversold relative to its 30-day fair value range of $0.62 to $0.75.
Technical Outlook: Technically, MDXH is in a downtrend. The price is currently testing key support at $0.55. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.80 (+228.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDXH is in a downtrend. The price is currently testing key support at $0.55. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.80 (+228.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.62 -
$0.75
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 228.5% below Wall St target ($1.80)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.62 -
$0.75
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.55
Resistance Level
$0.70
Current Trend
Downtrend
Technical data as of
Sep 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.44
Wall Street Target
$1.80
(+228.5%)
Revenue Growth (YoY)
2.3%
Profit Margin
-32.7%
Share & Embed Analysis
Last updated: September 28, 2026 6:38 PM ET
Data refreshes hourly during market hours. Next update: 7:38 PM
Data refreshes hourly during market hours. Next update: 7:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDXH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 33 SELL |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 42 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 39 SELL |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 67 BUY |
